PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\', \'Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.\', \'ImmunologyToday, Universal Scientific Education and Research Network (USERN), Tehran, Iran.\', \'Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. mohamadsani495@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00210-020-02034-6
?:doi
?:hasPublicationType
?:journal
  • Naunyn-Schmiedeberg\'s archives of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33416933
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.836
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all